Global /Canada /Healthcare /Drug Manufacturers - General /AVCR

Avricore Health Inc.

AVCR

• TSXV: AVCR • Delayed

0.0650CAD 0%

0.0466 USD

As of 12 June 2026, Avricore Health Inc. has a market cap of $4.71M USD, ranking #44697 globally and #2051 in Canada. It ranks #3962 in the Healthcare sector, and #1271 in the Drug Manufacturers - General industry.

Global Rank

44697

Country Rank

2051

Sector Rank

3962

Industry Rank

1271

Key Stats

Market Cap

$4.71MUSD

6.58M CAD

Enterprise Value

$4.33MUSD

6.04M CAD

Revenue (TTM)

$1.37MUSD

1.92M CAD

EBITDA (TTM)

-$414.28KUSD

-578.03K CAD

Net Income (TTM)

-$1.16MUSD

-1.63M CAD

EBITDA Margin

-30%

Profit Margin

-85%

PS Ratio

3.4

PB Ratio

5.1

Company Profile

Country (HQ)

Canada

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Rodger Seccombe open_in_new

Founded

1996

Website

avricore.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	0%	-8.3%	-13%	18%	30%	18%	-78%	-75%

News

Markets

Exchange	Ticker	Price	Quotes
TSX Venture Exchange (TSXV) MIC: XTSX PRIMARY	AVCR Avricore Health Inc ISIN: CA0545211090 Shares Out.: Shares Outstanding: 101.29M¹ Shares Float: 91.585M² TV: TradingView: TSXV: AVCR SA: Stock Analysis: TSXV: AVCR YF: Yahoo Finance: AVCR.V GF: Google Finance: CVE: AVCR BA: Barron's: AVCR MS: Morningstar: XTSX: AVCR	0.0650 CAD	TV: TradingView: TSXV: AVCR SA: Stock Analysis: TSXV: AVCR YF: Yahoo Finance: AVCR.V GF: Google Finance: CVE: AVCR BA: Barron's: AVCR MS: Morningstar: XTSX: AVCR
Cboe Canada (NEO) MIC: NEOE	AVCR Avricore Health Inc ISIN: CA0545211090 TV: TradingView: NEO: AVCR SA: Stock Analysis: NEO: AVCR YF: Yahoo Finance: AVCR.NE GF: Google Finance: NEO: AVCR BA: Barron's: AVCR MS: Morningstar: NEOE: AVCR	0.0550 CAD	TV: TradingView: NEO: AVCR SA: Stock Analysis: NEO: AVCR YF: Yahoo Finance: AVCR.NE GF: Google Finance: NEO: AVCR BA: Barron's: AVCR MS: Morningstar: NEOE: AVCR
Frankfurt Stock Exchange (FRA) MIC: XFRA	8VP1 Avricore Health Inc ISIN: CA0545211090 TV: TradingView: FWB: 8VP1 SA: Stock Analysis: FRA: 8VP1 YF: Yahoo Finance: 8VP1.F GF: Google Finance: FRA: 8VP1 BA: Barron's: 8VP1 MS: Morningstar: XFRA: 8VP1	0.0350 EUR	TV: TradingView: FWB: 8VP1 SA: Stock Analysis: FRA: 8VP1 YF: Yahoo Finance: 8VP1.F GF: Google Finance: FRA: 8VP1 BA: Barron's: 8VP1 MS: Morningstar: XFRA: 8VP1
OTC Markets (OTCMKTS / OTC) MIC: OTCM	AVCRF Avricore Health Inc ISIN: CA0545211090 TV: TradingView: OTC: AVCRF SA: Stock Analysis: OTC: AVCRF YF: Yahoo Finance: AVCRF GF: Google Finance: OTCMKTS: AVCRF BA: Barron's: AVCRF MS: Morningstar: PINX: AVCRF	0.0465 USD	TV: TradingView: OTC: AVCRF SA: Stock Analysis: OTC: AVCRF YF: Yahoo Finance: AVCRF GF: Google Finance: OTCMKTS: AVCRF BA: Barron's: AVCRF MS: Morningstar: PINX: AVCRF

Show all 4 markets

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Avricore Health Inc.

Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

Similar Companies

Industry: Drug Manufacturers - General (Canada)

Name	Market Cap (USD) diff.	PE	Country
Xenon Pharmaceuticals Inc. NASDAQ: XENE	$5.39B 114K%	-	Canada
Knight Therapeutics Inc. TSX: GUD	$518.65M 725.1M CAD 11K%	-	Canada
Milestone Pharmaceuticals Inc. NASDAQ: MIST	$223.22M 5K%	-	Canada
Satellos Bioscience Inc. TSX: MSCL	$155.11M 216.85M CAD 3K%	-	Canada
BioSyent Inc. TSXV: RX	$118.63M 165.86M CAD 2K%	18.5	Canada
Helix BioPharma Corp. TSX: HBP	$110.36M 154.28M CAD 2K%	-	Canada

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 16M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 12M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 8M%	97.4	United States
Roche Holding AG SIX: RO	$320.56B 256.25B CHF 7M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.45B 215.59B GBP 6M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 6M%	15.1	United States

chevron_leftBack